Drug repurposing for the treatment of COVID-19

Drug repurposing for the treatment of COVID-19

Coronavirus disease 2019 (COVID-19) remains prevalent worldwide since its onset was confirmed in Wuhan, China in 2019. Vaccines against the causative virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have shown a preventive effect against the onset and severity of COVID-19, and so...

Full description

Bibliographic Details
Main Authors: Yuri Kato, Kazuhiro Nishiyama, Akiyuki Nishimura, Takamasa Noda, Kaori Okabe, Takahiro Kusakabe, Yasunari Kanda, Motohiro Nishida
Format: Article
Language:English
Published: Elsevier 2022-07-01
Series:Journal of Pharmacological Sciences
Subjects:
Eco-pharma
Cardiomyocyte
Transient receptor potential channel
NADPH oxidase
Protein–protein interaction
Online Access:http://www.sciencedirect.com/science/article/pii/S1347861322000342

Internet

http://www.sciencedirect.com/science/article/pii/S1347861322000342

Similar Items